STORRS, Conn. — Researchers with the University of Connecticut are using mRNA vaccine technology to tackle the poultry health pathogen — infectious bronchitis virus (IBV).
The development of a mRNA vaccine would make it similar to the one used for the human COVID-19 vaccines. These vaccines do not contain live viruses, instead a piece of the genetic code of the virus is used that spikes a protein that triggers the immune system.
The researchers with UConn’s College of Agriculture, Health and Natural Resources and College of Liberal Arts and Sciences are looking into a novel protein-based nanoparticle that would. . .
Register or Login to keep reading
Thank you for your interest in accessing the complete content. To continue reading, please register for free. By registering, you'll gain full access to our valuable resources, updates, and insights.
If you already have an account please Log In.
